PMC:7376845 / 619-812
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T4 | 118-125 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T5 | 180-187 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 33 | 116-117 | Gene | denotes | S | Gene:43740568 |
| 34 | 129-137 | Species | denotes | SARS-CoV | Tax:694009 |
| 35 | 40-50 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 46 | 167-177 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T19 | 40-48 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T20 | 40-44 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T21 | 129-137 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T22 | 129-133 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T23 | 167-175 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T24 | 167-171 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 10-13 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | Aim |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T5 | 118-125 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T6 | 180-187 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7 | 10-13 | Sentence | denotes | Aim |
| T8 | 14-153 | Sentence | denotes | The cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed. |
| T9 | 155-162 | Sentence | denotes | Methods |